133 related articles for article (PubMed ID: 38093665)
1. Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Costa A; Carmosino I; Scalzulli E; Minotti C; De Propris MS; Masucci C; Passucci M; Bisegna ML; Ielo C; Pepe S; Diverio D; Martelli M; Breccia M
Eur J Haematol; 2024 Apr; 112(4):654-657. PubMed ID: 38093665
[No Abstract] [Full Text] [Related]
2. Early death in acute promyelocytic leukemia: time to redefine risk groups.
Salman MY; Ofran Y
Haematologica; 2022 Jul; 107(7):1498-1499. PubMed ID: 35081691
[No Abstract] [Full Text] [Related]
3. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
Wen J; Xu F; Zhou Q; Shi L; Liu Y; Yue J; Zhang Y; Liang X
BMC Cancer; 2023 Jan; 23(1):27. PubMed ID: 36611025
[TBL] [Abstract][Full Text] [Related]
4. An effective early death scoring system for predicting early death risk in
Cai P; Wu Q; Wang Y; Yang X; Zhang X; Chen S
Leuk Lymphoma; 2020 Aug; 61(8):1989-1995. PubMed ID: 32228267
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of Acute Promyelocytic Leukemia and Primary Plasma Cell Leukemia: Careful Consideration in Diagnosis.
Park JH; Choi HW; Shin MG
Ann Lab Med; 2022 Mar; 42(2):278-281. PubMed ID: 34635620
[No Abstract] [Full Text] [Related]
6. High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
Yoon JH; Kim HJ; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
J Hematol Oncol; 2017 Jan; 10(1):30. PubMed ID: 28114959
[TBL] [Abstract][Full Text] [Related]
7. [Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis].
Matsuda H; Misawa K; Ochiai T; Fujioka I; Iwasaki H; Iwao N; Koike M; Komatsu N
Rinsho Ketsueki; 2020; 61(10):1511-1513. PubMed ID: 33162450
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia (APL) with an unusual cytogenetic presentation.
Yorulmazoglu E; Gezer S; Gregory SA; Hsu WT
Med Pediatr Oncol; 1998 Jan; 30(1):69-72. PubMed ID: 9371394
[No Abstract] [Full Text] [Related]
9. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
[TBL] [Abstract][Full Text] [Related]
10. Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
Tallman MS; Manji GA
Blood Cells Mol Dis; 2011 Feb; 46(2):173-4. PubMed ID: 21227722
[No Abstract] [Full Text] [Related]
11. 100-Year-Old Haematologica Images: Acute Promyelocytic Leukemia.
Balduini CL
Haematologica; 2020; 105(2):245. PubMed ID: 32005649
[No Abstract] [Full Text] [Related]
12. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
Miller WH
Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
[No Abstract] [Full Text] [Related]
13. Misleading acute promyelocytic leukemia morphology.
Wuillème S; Le Bris Y
Blood; 2015 Jun; 125(24):3815. PubMed ID: 26266276
[No Abstract] [Full Text] [Related]
14. Acute promyelocytic leukemia during pregnancy.
Ganzitti L; Fachechi G; Driul L; Marchesoni D
Fertil Steril; 2010 Nov; 94(6):2330.e5-6. PubMed ID: 20447623
[TBL] [Abstract][Full Text] [Related]
15. Institutional factors associated with early mortality of newly diagnosed acute promyelocytic leukemia.
Matsuda K; Jo T; Matsui H; Fushimi K; Yasunaga H; Sugimoto K
Blood Cancer J; 2022 Dec; 12(12):167. PubMed ID: 36522307
[No Abstract] [Full Text] [Related]
16. JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).
Asou N; Fujita H; Shinagawa K
Int J Hematol; 2017 Oct; 106(4):459-470. PubMed ID: 28856623
[No Abstract] [Full Text] [Related]
17. Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia.
Lou Y; Ma Y; Sun J; Suo S; Tong H; Qian W; Mai W; Meng H; Jin J
Ann Hematol; 2017 Nov; 96(11):1793-1800. PubMed ID: 28823055
[TBL] [Abstract][Full Text] [Related]
18. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R
Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985
[No Abstract] [Full Text] [Related]
19. Clinical spectrum of extramedullary acute promyelocytic leukemia.
Menéndez A; González A; Cabrera H; Mesa J; Martínez G; Espinoza E; Hernández P
Eur J Haematol; 2000 Mar; 64(3):201-3. PubMed ID: 10997887
[No Abstract] [Full Text] [Related]
20. Acute promyelocytic leukemia: an update.
Baer MR; Bloomfield CD
Ann Oncol; 1991 Jun; 2(6):392-3. PubMed ID: 1768623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
